Clinical Trial Record

Return to Clinical Trials

Non-hypovascular Solid Pancreatic Lesions: Role of EUS


2016-05-01


2018-05


2019-05


154

Study Overview

Non-hypovascular Solid Pancreatic Lesions: Role of EUS

Vascular pattern of solid pancreatic lesions (SPLs) has been investigated by different abdominal imaging modalities and by contrast-enhanced endoscopic ultrasonography (CE-EUS). Compared with surrounding pancreatic parenchyma three different patterns have been described: hypo-, iso-, and hypervascular. The majority of SPLs are hypovascular, and the diagnostic relevance of hypoenhanced pattern to predict pancreatic adenocarcinoma (PDAC) is well established. Differently, iso- and hypervascular pattern is not specific and can be expressed by several SPLs, with different clinical behavior and management. To date, poor is know about the role of EUS in differential diagnosis of non-hypovascular SPLs and features associated with malignancy.

N/A

  • Solid Pancreatic Neoplasms
  • Endoscopic Ultrasound
  • DIAGNOSTIC_TEST: Endoscopic ultrasound-fine needle biopsy
  • 1296CESC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2018-11-08  

N/A  

2019-05-05  

2018-11-09  

N/A  

2019-05-07  

2018-11-13  

N/A  

2019-05  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
Primary Outcome MeasuresMeasure DescriptionTime Frame
Upstream dilation of the main pancreatic ductPercentage of cases with upstream dilation of main pancreatic duct will be recorded.6 months
Vascular pattern (iso or hypervascular)Percentage of cases with iso-vascular or hyper-vascular pattern will be recorded.6 months
Lesion borders (smooth or irregular)Percentage of cases with smooth or irregular borders will be recorded.6 months
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Presence of one or more solid pancreatic lesions preliminary evaluated by contrast-enhanced computed tomography (CE-CT) and/or contrast enhanced magnetic resonance imaging (CE-MRI) reporting a non-hypovascular contrast pattern (e.g., iso- or hypervascular).

  • Exclusion Criteria:

  • Patients with associated chronic pancreatitis features (e.g., pancreatic calcifications)
  • Lesion with hypovascular pattern at CE-EUS.
  • Lesion not found or non pancreatic at EUS.
  • Patients refusing to be included in the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available